Financhill
Back

Molecular Templates Quote, Financials, Valuation and Earnings

Molecular Templates Price Quote

$0.45

Molecular Templates Key Stats

Sell
11
Molecular Templates (MTEM) is a Sell

Day range:
$0.45 - $0.45
52-week range:
$0.30 - $6.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.12
P/B ratio:
0.42%

Volume:
113.1K
Avg. volume:
9M
1-year change:
-91.83%
Market cap:
$3M
Revenue:
$52.6M
EPS:
$-2.78

How Much Does Molecular Templates Make?

Is Molecular Templates Growing As A Company?

  • What Is Molecular Templates's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.97%
  • What Is Molecular Templates's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Molecular Templates Stock Price Performance

What Is Molecular Templates 52-Week High & Low?

Molecular Templates Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Molecular Templates?

Is Molecular Templates Cash Flow Positive?

  • What Is MTEM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.9M
  • What Is Molecular Templates’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Molecular Templates’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $8K

Molecular Templates Return On Invested Capital

  • Is Management Doing A Good Job?
    MTEM return on invested capital is -510.12%
  • What Is Molecular Templates Return On Assets?
    ROA measures how assets are converting to revenues and is -46.29%
  • What Is MTEM Return On Equity?
    ROE is a measure of profitability and is -510.12%

Molecular Templates Earnings Date & Stock Price

Molecular Templates Competitors

  • Who Are Molecular Templates's Competitors?
    Below is a list of companies who compete with Molecular Templates or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Protalix BioTherapeutics Inc (PLX)
    • Catheter Precision Inc (VTAK)

Molecular Templates Dividend Yield

Molecular Templates Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -166.19%
Revenue: -97.15% -90.67%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 18.00
Upside from Last Price: 3900%

Major Shareholders

  • How many MTEM shares are owned by institutional investors?
    5.8M MTEM shares are owned by institutional investors
  • How many MTEM shares are owned by insiders?
    6M MTEM shares are owned by insiders